Title : Cost-effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in Australia.

Pub. Date : 2013 Dec

PMID : 24279856






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIMS: This study aims to assess the cost-effectiveness in Australia of screening CYP2C19 loss-of-function (LoF) alleles to guide selection of clopidogrel or ticagrelor for individuals with acute coronary syndrome who are likely to undergo coronary stenting. Ticagrelor cytochrome P450 family 2 subfamily C member 19 Homo sapiens